return to news
  1. Procter & Gamble Health Q3 Results: Net profit up 17% to ₹269 crore; ₹110 interim dividend announced

Market News

Procter & Gamble Health Q3 Results: Net profit up 17% to ₹269 crore; ₹110 interim dividend announced

Upstox

2 min read | Updated on February 11, 2025, 18:47 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Procter & Gamble Hygiene and Health Care Ltd (PGHH), announcing its Q3 FY25 earnings on Tuesday, reported a net profit of ₹269 crore, up 17% year-on-year (YoY). On a sequential basis, its net profit increased by 27%.

Stock list

Procter & Gamble Hygiene and Health Care shares ended in the red on Tuesday

Procter & Gamble Hygiene and Health Care shares ended in the red on Tuesday

Procter & Gamble Hygiene and Health Care Ltd (PGHH) on Tuesday posted a 17% jump in its net profit for the third quarter of the current fiscal year (Q3 FY25) to ₹268.59 crore as against ₹228.9 crore posted in the year-ago period.

The company’s revenue from operations for the reporting quarter stood at ₹1,247.63 crore, up 10.3% from ₹1,131 crore reported in Q3 FY24.

The company also declared an interim dividend of ₹110 per equity share with a face value of ₹10 each. The record date for the dividend has been set as February 20, 2025, and the payment will be made on or before March 7, 2025.

“...Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2024-25 of ₹ 110 per Equity Share (Face Value of ₹10/- each). The dividend shall be paid on or before March 7, 2025,” the company said.

On a sequential basis, the company’s net profit grew by 26.7% from ₹211.9 crore, while its revenue increased by 9.9% from ₹1,135.16 in Q3 FY24.

The shares of Procter & Gamble Hygiene and Health Care ended 1.85% down at ₹13,890.30 apiece on the NSE on Tuesday. The company’s market capitalisation stood at ₹45,088.94 crore.

Commenting on the Q3 FY results, Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care Ltd, said, “The Company has delivered strong double-digit growth across both topline and bottom line in the quarter. This has been led by our continued focus on delighting all consumers with superior propositions and executing the integrated growth strategy– a focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization. Our strategy has enabled these solid results and is a foundation for balanced growth and value creation.”

Upstox

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story